Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/1759-7714.12414 http://scihub22266oqcxt.onion/10.1111/1759-7714.12414 C5334301!5334301!28207203     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Thorac+Cancer 2017 ; 8 (2): 106-13 Nephropedia Template TP {{tp|p=28207203|t=2017. Is chronic kidney disease an adverse factor in lung cancer clinical outcome? A propensity score matching study |pdf=|usr=}}{{28207203}} gab.com Text Is chronic kidney disease an adverse factor in lung cancer clinical outcome A propensity score matching study JO: Thorac Cancer http://www.kidney.de/pget.php?&tw=1&pmid=28207203 #FOAvip Background: Comorbidity has a great impact on lung cancer survival. Renal function status may affect treatment decisions and drug toxicity. The survival outcome in lung cancer patients with coexisting chronic kidney disease (CKD) has not been fully evaluated. We hypothesized that CKD is an independent risk factor for mortality in patients with lung cancer. Methods: A retrospective, propensity?matched study of 434 patients diagnosed between June 2004 and May 2012 was conducted. CKD was defined as estimated glomerular filtration rate <60?mL/minute. Lung cancer and coexisting CKD patients were matched 1:1 to patients with lung cancer without CKD. Results: Age, gender, smoking status, histology, and lung cancer stage were not statistically significantly different between the CKD and non?CKD groups. Kaplan?Meier survival analysis demonstrated a median survival of 7.26?months (95% confidence interval [CI] 6.06?8.46) in the CKD group compared with 7.82?months (95% CI 6.33?9.30) in the non?CKD group (P?=?0.41). Lung cancer stage?specific survival is not affected by CKD. Although lung cancer patients with CKD presented with an increased risk of death of 6%, this result was not statistically significant (hazard ratio 1.06, 95% CI 0.93?1.22; P?=?0.41). Conclusion: According to our limited experience, CKD is not an independent risk factor for survival in lung cancer patients. Clinicians should not be discouraged to treat lung cancer patients with CKD. Twit Text FOAVip Is chronic kidney disease an adverse factor in lung cancer clinical outcome A propensity score matching study ????Thorac Cancer http://www.kidney.de/pget.php?&tw=1&pmid=28207203 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28207203 #FOAvip English Wikipedia <ref>{{Cite pmid|28207203}}</ref> Is chronic kidney disease an adverse factor in lung cancer clinical outcome? A propensity score matching study #MMPMID28207203 Lu M; Chen M; Lin C; Tseng Y; Huang Y; Liu H; Tsai Y Thorac Cancer 2017[Mar]; 8 (2): 106-13 PMID28207203show ga Background: Comorbidity has a great impact on lung cancer survival. Renal function status may affect treatment decisions and drug toxicity. The survival outcome in lung cancer patients with coexisting chronic kidney disease (CKD) has not been fully evaluated. We hypothesized that CKD is an independent risk factor for mortality in patients with lung cancer. Methods: A retrospective, propensity?matched study of 434 patients diagnosed between June 2004 and May 2012 was conducted. CKD was defined as estimated glomerular filtration rate <60?mL/minute. Lung cancer and coexisting CKD patients were matched 1:1 to patients with lung cancer without CKD. Results: Age, gender, smoking status, histology, and lung cancer stage were not statistically significantly different between the CKD and non?CKD groups. Kaplan?Meier survival analysis demonstrated a median survival of 7.26?months (95% confidence interval [CI] 6.06?8.46) in the CKD group compared with 7.82?months (95% CI 6.33?9.30) in the non?CKD group (P?=?0.41). Lung cancer stage?specific survival is not affected by CKD. Although lung cancer patients with CKD presented with an increased risk of death of 6%, this result was not statistically significant (hazard ratio 1.06, 95% CI 0.93?1.22; P?=?0.41). Conclusion: According to our limited experience, CKD is not an independent risk factor for survival in lung cancer patients. Clinicians should not be discouraged to treat lung cancer patients with CKD. äIs chronic kidney disease an adverse factor in lung cancer clinical ou(epmc).pdf DeepDyve Pubget Overpricing